zeranol has been researched along with Arteriosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Dai, S; Deng, W; Duan, J; Lu, Y; Ren, J; Wu, Y | 1 |
| Cheng, J; Dai, S; Duan, J; Ge, Q; Lu, Y; Ren, J; Wu, Y; Yu, Y; Zhang, Y; Zhao, X; Zuo, P | 1 |
2 other study(ies) available for zeranol and Arteriosclerosis
| Article | Year |
|---|---|
Alpha-Zearalanol, a phytoestrogen for cardiovascular therapy.
Topics: Arteriosclerosis; Estrogen Replacement Therapy; Female; Humans; Phytoestrogens; Zeranol | 2004 |
Phytoestrogen alpha-zearalanol inhibits atherogenesis and improves lipid profile in ovariectomized cholesterol-fed rabbits.
Topics: Animals; Aorta; Apolipoprotein A-I; Apolipoproteins B; Arteriosclerosis; Cholesterol; Diet, Atherogenic; Estradiol; Estrogens; Female; Histocytochemistry; Lipids; Organ Size; Ovariectomy; Phytoestrogens; Rabbits; Triglycerides; Uterus; Zeranol | 2004 |